FDA Approved: ZYDELIG — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved ZYDELIG (idelalisib) from Gilead Sciences as a new molecular therapy for adults with relapsed or refractory follicular lymphoma, chronic lymphocyti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• Zydelig (idelalisib)

Snippet

ORIG AP for ZYDELIG (IDELALISIB)